ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 72

The Single-cell Transcriptomic Landscape of NZB/W Murine Lupus at Early and Late Stages of Disease

Paul Hoover1, Tom Eisenhaure 2, David Lieb 2, Anne Davidson 3 and Nir Hacohen 2, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Cambridge, MA, 3Feinstein Institutes for Medical Research, Manhasset

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: glomerulonephritis and systemic lupus erythematosus (SLE), Lupus, Lupus nephritis, Mouse model

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Animal Models Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis is a complex and heterogeneous disease characterized by infiltrating immune cells in damaged kidney tissue. While mouse models have enabled mechanistic studies of lupus nephritis, immune and kidney cell types and states are incompletely characterized. Thus, shared cells and pathways between mouse and human lupus nephritis remain unrecognized and could provide the basis for targeted studies as well as engineering existing mouse models to better reflect human disease. To provide a comprehensive view of active leukocytes in a common model of mouse lupus nephritis, NZB/W, we measured the transcriptomes of single cells from murine kidneys and as well as spleens at early and late stages of kidney disease.

Methods: NZB/W female mice were generated and followed clinically. Kidneys and spleens from NZB/W mice were harvested for analysis from two 22-week-old non-proteinuric and two 37-week-old proteinuric mice. Single immune and parenchymal cells from digested kidney, and immune cells from spleen, were collected by flow cytometric cell sorting. We used the 10X Chromium 5’ kit for single-cell encapsulation into droplets for library generation and next-generation sequencing for ~50,000 reads per cell. After normalization, single-cell transcriptomes passing quality metrics ( >500 genes and < 25% mitochondrial content) were analyzed with unsupervised clustering (Seurat 3.0).

Results: We profiled 32,969 single cells collected from kidneys and spleens from NZB/W lupus mice at early and late stages of kidney disease (pre- and proteinuric, 2 mice per disease stage). Using unsupervised transcriptome analysis we discovered 27 distinct cellular clusters. Of these, 15 were immune cell clusters reflecting distinct subsets of T, B, and myeloid cells in both damaged kidney tissue and the spleen; the remaining 12 cell clusters were non-hematopoietic cells reflecting kidney cell types and states in early and late stages of kidney disease. Comparing cells from the same organ type (kidney or spleen) harvested from different mice at identical disease stages revealed highly similar immune and non-hematopoietic cell clusters, indicating reproducibility across animals and minimal batch effect.

Conclusion: By measuring the transcriptomes from single cells collected from damaged murine kidney tissue and spleens at early and late stages of kidney disease (pre-proteinuric and proteinuric), this study provides a comprehensive view of active leukocytes of lupus nephritis in a common model, NZB/W. We discovered 27 distinct murine cellular clusters reflecting multiple T, B, and myeloid cell subsets, as well as non-hematopoietic kidney cells types. We will compare NZB/W immune and kidney cellular clusters to those recently discovered in human lupus nephritis patients by single cell transcriptome profiling (Arazi et. al, Nature Immunology, 2019; Der et. al. Nature Immunology, 2019). We expect to identify new and better understand existing cells and pathways shared between human mouse lupus nephritis. We anticipate this approach can incorporate other common mouse models of lupus nephritis to better understand how each is related to human disease.


Disclosure: P. Hoover, None; T. Eisenhaure, None; D. Lieb, None; A. Davidson, None; N. Hacohen, None.

To cite this abstract in AMA style:

Hoover P, Eisenhaure T, Lieb D, Davidson A, Hacohen N. The Single-cell Transcriptomic Landscape of NZB/W Murine Lupus at Early and Late Stages of Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-single-cell-transcriptomic-landscape-of-nzb-w-murine-lupus-at-early-and-late-stages-of-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-single-cell-transcriptomic-landscape-of-nzb-w-murine-lupus-at-early-and-late-stages-of-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology